Cellular microparticles for tumor targeting delivery: from bench to bedside
- 11 May 2020
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (46) , 6171-6188
Abstract
Within the past few years, cell derived microparticles (MPs) have emerged as a highly potent natural drug delivery system for tumor therapy. We and others have engineered different cells to obtain eleven kinds of MPs, which efficiently delivered antitumor agents to recipient cells and achieved ideal treatment outcomes in a great number of rodent tumor models. More significantly, autologous tumor cell derived MPs packaging chemotherapeutic drugs were demonstrated to be safe and tolerable and accomplished decent objective clinical response in lung cancer patients in clinical settings, leading to their approval as a novel biotherapy for treating malignancies in China. In this feature article, we review MP mediated tumor targeting delivery. The impact of tumor cell derived MPs on tumor progression and metastasis will be briefly summarized. Different means to prepare, label and characterize MPs will be introduced. Advantages and limitations of distinctive cargo encapsulation strategies will be outlined and compared. Tumor cell MP mediated in vivo transport processes will be reviewed comprehensively. Representative MPs shed by platelets, endothelial cells, macrophages, and dendritic cells will be selected to showcase their advantages in tumor targeting delivery. Multifarious therapeutic agents, including chemotherapeutic drugs, oncolytic adenovirus, nucleic acids, antigens, antibodies, to name a few, have been transported to their targets for corresponding cancer therapies. Current challenges and future opportunities on translating MPs for tumor targeting delivery will be provided in the end.Keywords
Funding Information
- National Natural Science Foundation of China (31700867)
- National Natural Science Foundation of China (31972927)
- National Natural Science Foundation of China (81627901)
- National Natural Science Foundation of China (81672937)
- National Natural Science Foundation of China (81773653)
- National Natural Science Foundation of China (81803018)
- National Natural Science Foundation of China (81974459)
- National Key Research and Development Program of China (2018YFA0208900)
- National Key Research and Development Program of China (2015CB931802)
- Huazhong University of Science and Technology (3004170130)
- Huazhong University of Science and Technology (2018QYTD01)
This publication has 99 references indexed in Scilit:
- Soft fibrin gels promote selection and growth of tumorigenic cellsNature Materials, 2012
- Microparticles: major transport vehicles for distinct microRNAs in circulationCardiovascular Research, 2012
- Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic NicheCancer Research, 2011
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cellsProceedings of the National Academy of Sciences, 2011
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in MalignancyClinical Cancer Research, 2009
- Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivoJournal of Experimental Medicine, 2009
- Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumorsInternational Journal of Cancer, 2009